To represent this molecular characteristic we used glioblastoma cell lines, U87MG, and the same ones engineered to overexpress wild-type (wt) EGFR or EGFRvIII (Fig. 1A) to explore the iPA antiproliferative effect. The gene discussed is EGFR; the disease is glioblastoma.